Although recombinant human IL-15 (rhIL-15) can up-regulate the expression of DNAM-1 and TIGIT in a dose-dependent manner, DNAM-1 expression is significantly reduced during coculture of NK cells with ovarian cancer cell line spheroids or patient-derived tumor cells [194]. This evidence concerns the gene CD226 and ovarian carcinoma.